A H Clayton

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. ncbi request reprint Prevalence of sexual dysfunction among newer antidepressants
    Anita H Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville 22903, USA
    J Clin Psychiatry 63:357-66. 2002
  2. ncbi request reprint Antidepressants and sexual dysfunction: mechanisms and clinical implications
    Anita H Clayton
    University of Virginia School of Medicine, Charlottesville, VA
    Postgrad Med 126:91-9. 2014
  3. doi request reprint Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder
    Anita H Clayton
    Psychiatry and Neurobehavioral Sciences, University of Virginia, 2955 Ivy Rd, Northridge Ste 210, Charlottesville, VA 22903
    J Clin Psychiatry 74:1010-7. 2013
  4. doi request reprint Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousal
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 9:2040-6. 2012
  5. doi request reprint Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivity
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 9:2027-39. 2012
  6. doi request reprint Etiology of female sexual dysfunction
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    Womens Health (Lond Engl) 9:135-7. 2013
  7. doi request reprint An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo
    Anita H Clayton
    University of Virginia, Charlottesville, VA 22908 062, USA
    J Sex Med 10:768-76. 2013
  8. doi request reprint Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia 22903, USA
    J Sex Marital Ther 39:132-43. 2013
  9. doi request reprint Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD)
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 6:730-8. 2009
  10. doi request reprint The impact of physical illness on sexual dysfunction
    Anita Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22908, USA
    Adv Psychosom Med 29:70-88. 2008

Detail Information

Publications56

  1. ncbi request reprint Prevalence of sexual dysfunction among newer antidepressants
    Anita H Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville 22903, USA
    J Clin Psychiatry 63:357-66. 2002
    ....
  2. ncbi request reprint Antidepressants and sexual dysfunction: mechanisms and clinical implications
    Anita H Clayton
    University of Virginia School of Medicine, Charlottesville, VA
    Postgrad Med 126:91-9. 2014
    ..Sexual dysfunction is frequently cited as a reason for nonadherence or discontinuation of treatment for depression...
  3. doi request reprint Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder
    Anita H Clayton
    Psychiatry and Neurobehavioral Sciences, University of Virginia, 2955 Ivy Rd, Northridge Ste 210, Charlottesville, VA 22903
    J Clin Psychiatry 74:1010-7. 2013
    ....
  4. doi request reprint Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousal
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 9:2040-6. 2012
    ..Brotto proposes to combine female sexual desire and arousal disorders in the Diagnostic and Statistical Manual of Mental Disorders, fifth edition...
  5. doi request reprint Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivity
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 9:2027-39. 2012
    ....
  6. doi request reprint Etiology of female sexual dysfunction
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    Womens Health (Lond Engl) 9:135-7. 2013
    ..They also show that specific types of sexual problems may be related more to nonshared environmental factors. Overall, the results suggest FSD is multifactorial...
  7. doi request reprint An evaluation of sexual functioning in employed outpatients with major depressive disorder treated with desvenlafaxine 50 mg or placebo
    Anita H Clayton
    University of Virginia, Charlottesville, VA 22908 062, USA
    J Sex Med 10:768-76. 2013
    ..The symptoms of major depressive disorder (MDD) include sexual dysfunction, but antidepressant pharmacotherapies are also associated with treatment-emergent sexual dysfunction...
  8. doi request reprint Validity of the decreased sexual desire screener for diagnosing hypoactive sexual desire disorder
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia 22903, USA
    J Sex Marital Ther 39:132-43. 2013
    ..The sensitivity of the decreased sexual desire screener was 0.946 in a North American trial and 0.960 in a European trial...
  9. doi request reprint Validation of the decreased sexual desire screener (DSDS): a brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD)
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 6:730-8. 2009
    ....
  10. doi request reprint The impact of physical illness on sexual dysfunction
    Anita Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22908, USA
    Adv Psychosom Med 29:70-88. 2008
    ..Thus, a separate section on medications that impair sexual functioning is presented. A table of common medications as a quick reference to their effects on each stage of the sexual cycle is also provided...
  11. doi request reprint Symptoms related to the menstrual cycle: diagnosis, prevalence, and treatment
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Health System, Charlottesville, VA 22908, USA
    J Psychiatr Pract 14:13-21. 2008
    ..g., with oral contraceptives). Treatment with oral contraceptives (OCs), particularly extended or continuous use, may significantly reduce the incidence of menstrual cycle-related symptoms...
  12. ncbi request reprint Epidemiology and neurobiology of female sexual dysfunction
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    J Sex Med 4:260-8. 2007
    ..Sexual dysfunction is a disturbance in sexual functioning involving one or multiple phases of the sexual response cycle or pain associated with sexual activity, while a sexual disorder includes both dysfunction and marked distress...
  13. doi request reprint Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women
    A H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    Womens Health (Lond Engl) 6:639-53. 2010
    ..The aim of this article is to present an overview of the pharmacology, clinical efficacy and safety of flibanserin. Flibanserin is an investigational drug that is not licensed for any indication in any country...
  14. ncbi request reprint Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
    Anita H Clayton
    Department of Psychiatry and Neurobehavioural Sciences, University of Virginia, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA 22903, USA
    Expert Opin Pharmacother 8:457-66. 2007
    ..Thus, bupropion has proven effective across a broad spectrum of depressive conditions, subtypes and comorbidities...
  15. ncbi request reprint An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    CNS Spectr 14:183-95. 2009
    ..The purpose of this investigation was to characterize the safety and tolerability of desvenlafaxine (administered as desvenlafaxine succinate) in treating depression...
  16. doi request reprint The impact of mental illness and psychotropic medications on sexual functioning: the evidence and management
    Anita H Clayton
    University of Virginia, Department of Psychiatry and Neurobehavioral Sciences, Charlottesville, VA 22903, USA
    J Sex Med 6:1200-11; quiz 1212-3. 2009
    ..Sexual dysfunction (SD) occurs frequently in patients with psychiatric illness...
  17. ncbi request reprint Potential role of androgens in the treatment of hypoactive sexual desire in women
    Anita H Clayton
    University of Virginia, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA, USA
    Womens Health (Lond Engl) 1:191-3. 2005
    ..This study suggests that supplemental testosterone may improve sexual desire in women with hypoactive sexual desire without hypoandrogenism...
  18. doi request reprint Female sexual dysfunction
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Northridge Suite 210, Charlottesville, VA 22903, USA
    Obstet Gynecol Clin North Am 36:861-76, xi. 2009
    ..A variety of treatment modalities exist, though current research has not yet provided Food and Drug Administration approved therapies for sexual disorders in women...
  19. doi request reprint Standards for clinical trials in sexual dysfunction in women: research designs and outcomes assessment
    Anita H Clayton
    University of Virginia Health System, Department of Psychiatry, and Neurobehavioral Sciences, Charlottesville, VA 22903, USA
    J Sex Med 7:541-60. 2010
    ..Clinical trial design in female sexual dysfunction (FSD) is an evolving science, with some areas of controversy...
  20. doi request reprint Female sexual dysfunction
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, PO Box 801210, Charlottesville, VA 22908 1210, USA
    Psychiatr Clin North Am 33:323-38. 2010
    ..A variety of treatment modalities exist, though current research has not yet provided Food and Drug Administration-approved therapies for sexual disorders in women...
  21. doi request reprint The pathophysiology of hypoactive sexual desire disorder in women
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA 22903, USA
    Int J Gynaecol Obstet 110:7-11. 2010
    ..A greater understanding of the complex pathophysiology of HSDD would improve the identification and management of women for whom low sexual desire is a concern...
  22. doi request reprint Validation of the sexual interest and desire inventory-female in hypoactive sexual desire disorder
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA, USA
    J Sex Med 7:3918-28. 2010
    ..The Sexual Interest and Desire Inventory-Female (SIDI-F) is a 13-item scale developed as a clinician-administered assessment tool to measure hypoactive sexual desire disorder (HSDD) severity in women...
  23. ncbi request reprint Major depressive disorder, antidepressants, and sexual dysfunction
    Anita H Clayton
    Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, 22908, USA
    J Clin Psychiatry 67:33-7. 2006
    ..The addition of antidotal therapy has been proven to be among the effective management strategies for sexual dysfunction. However, due to a lack of systematic data, additional studies are warranted to further investigate these findings...
  24. ncbi request reprint Recognition of depression among women presenting with menopausal symptoms
    Anita Clayton
    University of Virginia Healthsystem, Charlottlesville, VA 22908, USA
    Menopause 15:758-67. 2008
    ..Depression is particularly prevalent among women in the reproductive years. This article reviews research on the risk of depression during the transition to menopause and discusses screening methods and management options...
  25. ncbi request reprint Exploratory study of premenstrual symptoms and serotonin variability
    A H Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville, Virginia 22903, USA
    Arch Womens Ment Health 9:51-7. 2006
    ..The three groups exhibited potentially significant differences in several biological markers. This study's results are consistent with a hypothesis implicating serotonin in the generation of premenstrual symptomology...
  26. ncbi request reprint Sex differences in clinical presentation and response in panic disorder: pooled data from sertraline treatment studies
    A H Clayton
    University of Virginia School of Medicine, Charlottesville, VA 22903, USA
    Arch Womens Ment Health 9:151-7. 2006
    ..Gender differences in clinical presentation and response to sertraline treatment were examined for patients diagnosed with DSM-III-R panic disorder with or without agoraphobia...
  27. ncbi request reprint A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction
    Anita H Clayton
    University of Virginia, Charlottesville, VA 22903, USA
    J Clin Psychiatry 65:62-7. 2004
    ..Exploratory analyses of the association of testosterone and sexual functioning in women in the study were also performed...
  28. ncbi request reprint Sexual function and dysfunction in women
    Anita H Clayton
    Department of Psychiatry, University of Virginia Health System, Northridge Building, Suite 210, 2955 Ivy Road, Charlottesville, VA 22903, USA
    Psychiatr Clin North Am 26:673-82. 2003
    ..Interventions may also be multifaceted, ranging from sex education to psychotherapy to medical treatment. Restoration of sexual functioning is the goal of treatment, but more research is needed for true success to be realized...
  29. ncbi request reprint Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder
    Anita H Clayton
    University of Virginia, Department of Psychiatric Medicine, Charlottesville 22903, USA
    Int Clin Psychopharmacol 18:151-6. 2003
    ..These results suggest that reboxetine may be of particular benefit for patients at risk for sexual dysfunction with SSRIs...
  30. ncbi request reprint Combination therapy in the treatment of major depressive disorder complicated by fibromyalgia and menopause
    Anita H Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA 22903, USA
    Psychosomatics 43:491-3. 2002
  31. ncbi request reprint Female sexual dysfunction related to depression and antidepressant medications
    Anita H Clayton
    University of Virginia Health System, 2955 Ivy Road, Northridge Suite 210, Charlottesville, VA 22908, USA
    Curr Womens Health Rep 2:182-7. 2002
    ..Emerging data on the pathophysiology of sexual function and dysfunction, and new treatment options may lead to improved quality of life for women diagnosed with depression...
  32. ncbi request reprint Assessment of sexual functioning during the menstrual cycle
    A H Clayton
    University of Virginia, Charlottesville, USA
    J Sex Marital Ther 25:281-91. 1999
    ..The 24 women who returned for the second and third visits reported less frequent orgasms and less satisfaction from their orgasms premenstrually than during midcycle...
  33. ncbi request reprint Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder
    Anita H Clayton
    Department of Psychiatric Medicine, University of Virgina Health System, Charlottesville, Virginia 22903, USA
    J Sex Marital Ther 32:115-35. 2006
    ..Taken together, the results of the present investigation indicate that the SIDI-F is a reliable and valid measure of HSDD severity, independent of relationship issues...
  34. ncbi request reprint Burden of phase-specific sexual dysfunction with SSRIs
    Anita Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA, USA
    J Affect Disord 91:27-32. 2006
    ..This study examines phase-specific sexual dysfunction among patients who are being treated for major depression and who do not meet criteria for global sexual dysfunction...
  35. ncbi request reprint Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies
    Anita H Clayton
    Department of Psychiatric Medicine, University of Virginia Health System, Charlottesville, USA
    J Clin Psychiatry 67:736-46. 2006
    ..To compare the effects on sexual functioning and the antidepressant efficacy of once-daily bupropion extended release (XL) and escitalopram in adults with major depressive disorder (MDD)...
  36. ncbi request reprint Combination therapy in fibromyalgia
    A H Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville, VA 22908 0623, USA
    Curr Pharm Des 12:11-6. 2006
    ..Treatment should therefore be tailored accordingly. Thus, it is often necessary to combine different options in order to achieve the maximum benefit in patients suffering from fibromyalgia...
  37. ncbi request reprint Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction
    A H Clayton
    Department of Psychiatric Medicine, University of Virginia, Charlottesville 22903, USA
    J Clin Psychiatry 62:185-90. 2001
    ..Results show that sexual functioning improves after the addition of bupropion SR to SSRI treatment and continues to improve, after discontinuation of the SSRI, with bupropion SR treatment alone...
  38. ncbi request reprint Recognition and assessment of sexual dysfunction associated with depression
    A H Clayton
    Department of Psychiatric Medicine, University of Virginia School of Medicine, Charlottesville 22908, USA
    J Clin Psychiatry 62:5-9. 2001
    ..Appropriate evaluation of sexual functioning associated with depression could help reduce the enormous societal costs of this disorder...
  39. ncbi request reprint A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability
    Michael E Thase
    Department of Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Institute, Pittsburgh, PA, USA
    J Clin Psychopharmacol 26:482-8. 2006
    ..In conclusion, in this patient population (ie, relatively young, sexually active outpatients), bupropion XL was at least as effective as venlafaxine XR and had a significantly more favorable sexual side effect profile...
  40. doi request reprint Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression
    Robert H Howland
    Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
    Ann Clin Psychiatry 20:209-18. 2008
    ..To identify putative demographic and clinical variables that correlate with antidepressant response to the SNRI duloxetine in major depression...
  41. ncbi request reprint Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions
    George I Papakostas
    Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Int Clin Psychopharmacol 22:226-9. 2007
    ..This finding could, however, not be replicated when improvement in anxious/somatic symptoms was defined as a continuous measure...
  42. doi request reprint Sertraline in the treatment of panic disorder
    Cassandra D Hobgood
    University of Virginia Health System, Department of Psychiatry and Neurobehavioral Sciences, Charlottesville, Virginia 22903, USA
    Drugs Today (Barc) 45:351-61. 2009
    ..When reviewed in context with the efficacy trials, a compelling argument can be made for making sertraline a first choice among the serotonin reuptake inhibitors in the treatment of PD...
  43. ncbi request reprint Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14)
    Adrienne Keller
    Department of Psychiatric Medicine, University of Virginia, Charlottesville, 22908, USA
    J Sex Marital Ther 32:43-52. 2006
    ..Factor analysis confirms the construct validity of the CSFQ-14 as a global measure of sexual dysfunction. The CSFQ-14 and the individual scales exhibit strong internal reliability...
  44. doi request reprint Sexual functioning of Latino women seeking outpatient gynecologic care
    Kathie L Hullfish
    Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA 22908, USA
    J Sex Med 6:61-9. 2009
    ..A sample of Latino women from an ambulatory obstetrics and gynecology (Ob/Gyn) clinic were queried about their sexual functioning using the Changes in Sexual Functioning Questionnaire (CSFQ-14)...
  45. ncbi request reprint Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale
    Anita H Clayton
    Department of Psychiatry and Neurobehavioral Sciences, University of Virginia Health System, Charlottesville, VA 22908, USA
    J Clin Psychiatry 68:1860-6. 2007
    ..The objective of this study was to examine the impact of STS 6 mg/24 hours on various domains of sexual function in patients with major depressive disorder (MDD), using a patient-rated questionnaire...
  46. ncbi request reprint Gender differences in clinical psychopharmacology
    Anita H Clayton
    University of Virginia, Charlottesville, VA, USA
    J Clin Psychiatry 66:1191. 2005
  47. ncbi request reprint Chronic episodic disorders in women
    Julia K Warnock
    Department of Psychiatry, University of Oklahoma Health Sciences Center Tulsa, 4502 East 41st Street, Tulsa, OK 74135 2553, USA
    Psychiatr Clin North Am 26:725-40. 2003
    ..Thus, an increased understanding of the CED may result in improved treatment and functioning of many patients...
  48. ncbi request reprint Serotonergic activation rescues reproductive function in fasted mice: does serotonin mediate the metabolic effects of leptin on reproduction?
    Shannon D Sullivan
    Department of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA
    Biol Reprod 66:1702-6. 2002
    ..Together, these data demonstrate a permissive role for serotonergic systems in the metabolic control of reproduction and are consistent with the hypothesis that serotonergic neurons convey leptin signals to GnRH neurons...
  49. ncbi request reprint Female sexual dysfunctions: what controversy?
    Anita H Clayton
    University of Virginia, Charlottesville, USA
    J Clin Psychiatry 67:991-2. 2006
  50. ncbi request reprint Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment
    David J Nutt
    Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol, UK
    J Clin Psychiatry 67:46-9. 2006
    ..In addition, the faculty discussed the importance of patient psychoeducation and self-management as well as the ways in which disease models of depression affect treatment...
  51. ncbi request reprint Treating depression complicated by comorbid medical illness or anxiety
    Madhukar H Trivedi
    Department of Psychiatry and Mood Disorders Research Program and Clinic, University of Texas Southwestern Medical Center, Dallas, USA
    J Clin Psychiatry 68:e01. 2007
    ....
  52. ncbi request reprint Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects
    Jeffrey R Bishop
    University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA
    Neuropsychopharmacology 31:2281-8. 2006
    ..6; p=0.046). Furthermore, the 5HT2A -1438 GG genotype was a significant predictor of lower arousal scores (p=0.022) after accounting for other measures. There was no significant relationship between any outcome measure and GNB3 genotype...
  53. ncbi request reprint Assessing the onset of antidepressant-induced sexual dysfunction using interactive voice response technology
    Judith A Dunn
    Pfizer Global Research and Development, New London, Conn, USA
    J Clin Psychiatry 68:525-32. 2007
    ..The current study was designed to evaluate the validity of obtaining CSFQ data using interactive voice response (IVR) technology...
  54. doi request reprint Physician attitudes regarding hypoactive sexual desire disorder in a primary care clinic: a pilot study
    Veronica Harsh
    National Institutes of Mental Health, Behavioral Endocrinology, Bethesda, MD, USA
    J Sex Med 5:640-5. 2008
    ..Female sexual dysfunction (FSD), in particular, complaints of low desire, affects many American women. Despite the impact FSD may have on these women, many do not present their symptoms to their physicians...
  55. ncbi request reprint Sexual medicine education: review and commentary
    Sharon J Parish
    Albert Einstein College of Medicine, Bronx, NY, USA
    J Sex Med 4:259-67; quiz 268. 2007
    ..Sexual medicine education is an important and fundamental topic not adequately represented in most undergraduate and residency training programs...
  56. ncbi request reprint Biochemical evidence of the placebo effect during the treatment of menstrual migraines
    Anita H Clayton
    J Clin Psychopharmacol 25:400-1. 2005